baber/WOPTO huggingface dataset:
Patent DE-60114011-D1 (DE)
Inventor: DI SILVESTRO GIUSEPPE
IPC: C08K3/00
Filed: 2001-06-15
Granted: 2006-02-23
Abstract: The invention concerns concentrated solutions based on polyamide used for introducing an additive into a thermoplastic matrix. The concentrated solutions comprise a matrix and an additive, the matrix being a modified polyamide having a star-shaped or H-shaped structure.
Patent DE-60117036-D1 (DE)
Inventor: BOYLE ADRIAN
IPC: B23K26/36
Filed: 2001-10-26
Granted: 2006-04-13
Abstract: A semiconductor is cut by directing a green laser beam of high power, and subsequently directing a UV beam along the cut line. The first beam performs cutting with relatively rough edges and a high material removal rate, and the second beam completes the cut at the edges for the required finish, with a lower material quantity removal.
Patent DE-60120658-D1 (DE)
Inventor: FABBRI RAFFAELLA
IPC: A01N1/02
Filed: 2001-03-20
Granted: 2006-07-27
Abstract: In a method for cryopreserving fresh human oocytes, freezing and thawing solutions are used, which solutions include 1,2 propanediol (PROH) and sucrose at a concentration of at least 0.3 M. The oocytes are exposed for 13 - 15 minutes to a solution including 1.5 M PROH and 0.3 M sucrose before starting the freezing process.
Patent DE-60123167-D1 (DE)
Inventor: OKUDA NORIMASA
IPC: C07C59/11
Filed: 2001-05-31
Granted: 2006-11-02
Abstract: The present invention relates to:   a method for producing  alpha -hydroxycarboxylic acid, which comprises hydrolyzing cyanohydrin in the presence of a hydrocarbon solvent; a method for producing optically active  alpha -hydroxycarboxylic acid, which comprises: producing optically active cyanohydrin by performing a reaction between a carbonyl compound and hydrogen cyanide, using a solvent comprising at least one organic solvent selected from a group consisting of an alcoholic solvent, an ester solvent, an ethereal solvent and a carboxylic solvent; removing said organic solvent from said reaction solvent; and hydrolyzing the remaining reaction mixture without isolating optically active cyanohydrin; a method for producing optically active  alpha -hydroxycarboxylic acid, which comprises hydrolyzing optically active cyanohydrin, using at most 10 equivalents of mineral acid relative to said optically active cyanohydrin under the condition that maximum temperature when reacting is 90 DEG C or less; and a method for producing optically active crystalline  alpha -hydroxycarboxylic acid, which comprises crystallizing optically active  alpha -hydroxycarboxylic acid in an aqueous solution.
Patent DE-60132075-D1 (DE)
Inventor: RASTELLI LUCA K
IPC: C07K14/00
Filed: 2001-03-22
Granted: 2008-02-07
Abstract: An isolated polypeptide comprising an amino acid sequence having at least 80% sequence identity to the sequence SEQ ID NOS:2, 4, 6 or 8, polynucleotides encoding these peptides, and antibodies to the polypeptides are useful in treating cancers.
Patent DE-60134333-D1 (DE)
Inventor: JANSSEN WILHELMUS ARNOLDUS MAR
IPC: A01G9/12
Filed: 2001-10-15
Granted: 2008-07-17
Abstract: A plant guiding column for guiding a growing plant, provided with a first and second end and a substantially closed sidewall (1) extending between the first end (B) and the second end (T) and enclosing a growing space (2) such that the plant guiding column (Z) can guide the plant (P) from the first end (B) through the growing space (2) to the second end (T), the plant, via the second end (T) being able to grow out of the growing space (2) while undesired growth of at least shoots on the part of the plant present in the growing space (2) while undesired growth of at least shoots on the part of the plant present in the growing space (2) is substantially prevented. The invention also relates to an assembly comprising a number of plant guiding columns (Z) according to the invention, placed next to each other. Further, the invention relates to a shelter (17) which is kept at a distance above a ground surface (G) by a number of plant guiding columns (Z) according to the invention.
Patent DE-60137273-D1 (DE)
Inventor: FUNAHASHI YASUHIRO
IPC: A61P35/00
Filed: 2001-10-19
Granted: 2009-02-12
Abstract: The present invention concerns a process for preparing a compound represented by the following general formula (a-    
or a pharmacologically acceptable salt or hydrate thereof, which comprises reacting a compound repr    
with a compound represented by the following general formula (a-4) :   
wherein the residues R 1 , R 2 , R sa1  - R sa3 , R 300 , R 301  and Z are as defined in the claims.
Patent DE-60137855-D1 (DE)
Inventor: ANNIS VAUGHAN R
IPC: A61Q1/14
Filed: 2001-09-14
Granted: 2009-04-16
Abstract: Disclosed is a fibrous nonwoven web material and a method of manufacture thereof. The fibrous nonwoven web material includes natural cellulose fibers, manmade cellulose fibers and synthetic fibers. The manmade cellulose fibers are preferably high crystallinity cellulose fibers. The fibrous nonwoven web material has appreciable wet strength yet is capable of dispersing in most aqueous environments with only mild agitation. The fibrous nonwoven web material can be wet laid from an aqueous dispersion of fibers.
Patent DE-60144204-D1 (DE)
Inventor: JAKOBOVITS AYA
IPC: C12N15/113
Filed: 2001-01-26
Granted: 2011-04-21
Abstract: A novel gene (designated 84P2A9) and its encoded protein is described. While 84P2A9 exhibits prostate and testis specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, testis, kidney, brain, bone, skin, ovarian, breast, pancreas, colon, lymphocytic and lung cancers. Consequently, 84P2A9 provides a diagnostic and/or therapeutic target for cancers, and the 84P2A9 gene or fragment thcrcof, or its encoded protein or a fragment thereof used to elicit an immune response.
Patent DE-60201902-D1 (DE)
Inventor: ZEIRA ELDAD
IPC: H04J13/00
Filed: 2002-05-07
Granted: 2004-12-16
Abstract: A model for noise rise of users in relation to an interference measure, a pathloss and a desired signal to interference ratio is provided. For a selected user, a pathloss, an interference measure and a desired signal to interference ratio is determined. A noise rise for the selected user is determined using the determined interference measure, pathloss, desired signal to interference ratio and the noise rise model. The selected user transmission power level is estimated using the determined noise rise.
Patent DE-60206277-D1 (DE)
Inventor: MIKOSHIBA HISASHI
IPC: C09B31/14
Filed: 2002-01-30
Granted: 2005-10-27
Abstract: An ink useful for ink-jet recording comprises bis-type azo dye compound(s) having an improved heterocyclic structure that exhibits excellent properties as a black dye, presents a high-density and neutral black color having no other color tint, and provides improved excellent printing properties and favorable color tone. Ink comprises compound(s) represented by a structure of formula (I), formula (II) or formula (III). [Image] [Image] [Image] A, B : monovalent heterocyclic groups bonded to an azo group by a carbon atom of the monovalent heterocyclic group; m, n : 0 or 1; and M : a hydrogen atom or a monovalent positive ion. A and B of formula (II) are not both 1H-pyrazole-3-yl at the same time. An independent claim is also included for an ink-jet recording method comprising recording images with the ink.
Patent DE-60209810-D1 (DE)
Inventor: VAULTIER MICHEL
IPC: C07B61/00
Filed: 2002-12-20
Granted: 2006-05-04
Abstract: Aminoborane derivatives (I) are new.  Compounds of formula (I) are new: A-BH-NR<1>R<2> (I)  R<1>, R<2>  = 2-20C alkyl, 3-20C cycloalkyl or aralkyl, or R<1>+R<2> is alkylene, and preferably the groups are chiral;  A  = aryl, heteroaryl, vinyl, dienyl, polyenyl or alkynyl, all optionally substituted with alkyl, alkoxy, amino, dialkylamino, halo, CN, ester, amide, (thio)acetal, (thio)ketal, trialkylsilyl and dialkoxyboryl. Independent claims are also included for:  (i) a process for preparing compounds (I);  (ii) production of arylboratranes by reacting (I) with dihydroxyethylamines;  (iii) production of 2-aryl-5,5-dimethyl-1,3,2-dioxaborinanes by reacting (I) with 2,2-dimethyl-1,4-propanediol;  (iv) production of arylboronic acids by reaction (I) with excess methanol and hydrolyzing the resulting aryldimethoxyborane;  (v) production of B,B-diaryl-aminoboranes by reacting (I) with A-X (not defined) in the presence of a zero-valent palladium (Pd(0)) catalyst and a base;  (vi) production of compounds A-A by reacting (I) with A-Z (not defined) in the presence of a Pd(0) catalyst, a base and water.
Patent DE-60210750-D1 (DE)
Inventor: NIR SHLOMO
IPC: A01N47/36
Filed: 2002-01-03
Granted: 2006-05-24
Abstract: A herbicidal formulation comprising of incorporating the herbicide in a micelle or vesicle and adsorbing said micelle or vesicle containing herbicide on clay mineral. The formulation is suitable in particular for negatively charged herbicides at pH above 6. The herbicidal formulation provides slow release and reduced leaching of the herbicide to deep soil layers, thus reducing contamination of underground water and soil. Furthermore, the herbicide is maintained in the target vicinity, thus its efficiency is enhanced and a smaller concentration may be used.
Patent DE-60211139-D1 (DE)
Inventor: CAHILL KAY
IPC: A61K31/277
Filed: 2002-03-27
Granted: 2006-06-08
Abstract: The present invention relates to a pharmaceutical formulation comprising the drug 4'-cyano-alpha',alpha',alpha'-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide in a solid dispersion with PVP. In one embodiment, >50% of the drug is provided in the form of the R-enantiomer. The invention also relates to a daily pharmaceutical dose of the drug provided by such a formulation. In addition, the invention relates to the use of PVP in solid dispersion with the drug (in one embodiment wherein >50% of the 4'-cyano-alpha',alpha',alpha'-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide is provided in the form of the R-enantiomer) for increasing the bioavailability of the drug; for reducing inter-patient variability in plasma concentrations of the drug; for enhancing the storage stability of the drug; or for treating and/or reducing the risk of prostate cancer in a patient.
Patent DE-60213531-D1 (DE)
Inventor: MARKLUND GUNNAR
IPC: B65G47/31
Filed: 2002-09-02
Granted: 2006-09-14
Abstract: The invention concerns a means of momentary separation of lengths of timber (3) that are cross-fed in collected layers (9) on a main conveyor (1) comprising a number of adjacent means of transport (2), which primarily are of chain type, running in endless paths adjacent to each other and running at a determined speed (V1) define a first transport plane (Y1). For momentary separation of the lengths of timber transported in the layer there is in conjunction with the main conveyor (1) arranged a sub-conveyor (10) comprising several continuous first means of conveyance (11) of primarily belt type running at a speed (V2) that exceeds speed (V1) offset in relation to the continuous means of conveyance (2) of the main conveyor, arranged adjacent to each other in endless paths defining a second transport plane (Y2) carrying the timber that bridges part of the first transport plane (Y1), whereby the lengths of timber (3) transported on the main conveyor pass over the sub-conveyor. <IMAGE>
Patent DE-60219278-D1 (DE)
Inventor: NISHIMIYA YOSHIYUKI
IPC: C12P21/02
Filed: 2002-12-20
Granted: 2007-05-16
Abstract: The present invention provides an antifreeze protein, wherein thermal hysteresis activity and ice recrystallization inhibitory activity are artificially improved. The antifreeze protein is multimerized using a polypeptide linker to improve the thermal hysteresis and ice nuclei growth inhibitory effects in low concentrations. <IMAGE>
Patent DE-60224554-D1 (DE)
Inventor: OKAZOE TAKASHI
IPC: C07D317/18
Filed: 2002-10-30
Granted: 2008-02-21
Abstract: A fluorosulfonyl group-containing compound having a high polymerization reactivity, a process for its production, a sulfonyl group-containing polymerizable monomer led from the sulfonyl group-containing compound, and a polymer obtainable by polymerizing the sulfonyl group-containing polymerizable monomer, are provided. <??>A compound (3) is fluorinated to form a compound (4), and then, the compound (4) is subjected to a decomposition reaction to produce a compound (5). A preferred compound (5-1) of the compound (5) is thermally decomposed to produce a compound (7-1) having a high polymerization reactivity. <CHEM> <CHEM> <CHEM> wherein R<A> is a bivalent organic group such as a fluoroalkylene group, R<AF> is a group having R<A> fluorinated, or the same group as R<A>, each of R<B> to R<D> which are independent of one another, is a hydrogen atom, etc., each of R<BF> to R<DF> is a fluorine atom, etc., R<E> is a monovalent organic group, R<EF> is a group having R<E> fluorinated, or the same group as R<E>, E is a bivalent connecting group, E<F> is the same group as E, or a group having E fluorinated, E<F1> is a group formed by scission of E<F>, each of X<1> to X<3> is a hydrogen atom, etc., and each of X<1F> to X<3F> is a fluorine atom, etc. <IMAGE>
Patent DE-60225314-D1 (DE)
Inventor: SCHANN CHRISTIAN
IPC: C12M1/12
Filed: 2002-10-09
Granted: 2008-04-10
Abstract: This concerns a device whose filtering membrane ( 4 ) is gripped annularly at the periphery between an annular transverse wall ( 32 ) forming part of a drainage body and an axially oriented cylindrical wall ( 9 ) of an intake body, which lateral wall has an elastomer seal ( 13 ) which forms the edge thereof and by means of which this wall comes into contact with the membrane ( 4 ), this device being provided with a second seal ( 55 ) which has an arched profile, the external annular end ( 61 ) of which bears against said annular transverse wall ( 32 ) radially beyond said membrane ( 4 ), and the internal end ( 57 ) of which is connected to said seal ( 13 ) on the lateral wall ( 9 ) of said reservoir ( 5 ), hereinafter referred to as the first seal.
Patent DE-60231204-D1 (DE)
Inventor: AKERBERG DAG
IPC: H04J13/00
Filed: 2002-04-26
Granted: 2009-04-02
Abstract: The present invention discloses a carrier selection method for reducing interferences between mobile stations and/or base stations. A measure associated with a probability for a mobile station, having access to at least two carrier duplex entities, to produce interferences with adjacent external spectrum blocks is obtained. A candidate carrier duplex entity is then selected based on the interference measure. If the measure is lower than a first threshold value an inner carrier duplex entity should be selected as candidate carrier duplex entity. A mobile station in idle mode then locks to a downlink carrier of the candidate carrier duplex entity upon locking into a system. Mobile stations in an idle locked mode relocks to the downlink carrier of the carrier duplex entity, whereas mobile stations in an active mode perform a carrier handover to the candidate carrier duplex entity, unless already locked thereto.
Patent DE-60302283-D1 (DE)
Inventor: STIRM MICHAEL
IPC: B25D16/00
Filed: 2003-06-06
Granted: 2005-12-22
Abstract: An electrically powered rotary hammer comprising a hollow cylindrical spindle (18) mounted rotatably within a housing (2, 4) of the hammer with a tool holder arrangement (16) located at a forward end of the spindle for releasably holding a tool or bit within a forward tool holder portion of the spindle so as to enable limited reciprocation of the tool or bit within the spindle. An air cushion hammering mechanism (20, 21, 22) is located within the spindle for generating repeated impacts on the tool or bit and a rotary drive mechanism comprising a spindle drive gear (62) is mounted rotatably around the spindle for rotationally driving the spindle, or a part of the spindle, via an overload clutch. The overload clutch comprises a clutch ring (96) rotatably mounted around the spindle so as to have limited rotational movement with respect to the spindle drive gear and so as to be rotatably driven by the spindle drive gear via at least one spring element (94). At least one locking member (90) carried by the clutch ring is arranged so as to be shiftable with respect to the clutch ring from a first position in which the locking members transmit rotary drive from the clutch ring to the spindle. The overload clutch is arranged such that below a predetermined torque threshold the spring element or elements maintain(s) the spindle drive gear and the clutch ring in a relative rotational position in which the spindle drive gear locks the locking member or members in the first position and such that above the torque threshold the spring element or elements deform(s) and the relative rotational position of the spindle drive gear and the clutch ring changes so that the locking member or members move(s) out of the first position. <IMAGE>
Patent DE-60308602-D1 (DE)
Inventor: RUUSUNEN KIMMO
IPC: H04W36/18
Filed: 2003-05-22
Granted: 2006-11-09
Abstract: The invention relates to a method of updating an active set of a subscriber terminal in a cellular radio system and to a controller to be placed in a network part of a cellular radio system and used for updating an active set of a subscriber terminal. The method comprises measuring (302) the radio connections of at least one base station to the subscriber terminal in the subscriber terminal, and signalling downlink measurement information to a controller located in a network part of the cellular radio system, measuring (304) the radio connections of the subscriber terminal in at least one base station, and signalling uplink measurement information to the controller, updating (308) the radio connections included in the active set in the controller on the basis of the measurement information; deciding (310) the size of the active set in the controller on the basis of the measurement information, and signalling (316) the active set from the controller to the subscriber terminal. <IMAGE>
Patent DE-60326243-D1 (DE)
Inventor: OKADA HIDECHIKA
IPC: C07K16/28
Filed: 2003-06-30
Granted: 2009-04-02
Abstract: A monoclonal antibody falling within the category of human IgM which specifically recognizes HIV-infected cells and induces apoptosis is obtained. Using the obtained antibody, it is intended to provide a remedy for patients suffering from HIV-infection, which contains as the active ingredient a human IgM antibody capable of specifically reacting with HIV-infected cells, inducing apoptosis in the infected cells and thus disrupting the cells, etc.
Patent DE-60327585-D1 (DE)
Inventor: LUALDI GABRIELE
IPC: A61F2/34
Filed: 2003-08-01
Granted: 2009-06-25
Abstract: Femoral prosthesis for the articulation of a femur (11) in a corresponding acetabular seating (13) of a hip, comprising at least a femoral head (12) of a hemispherical shape, which is inserted into the acetabular seating (13), and pin means (18) which are engaged and clamped in a top portion (21) of the femur (11). The femoral head (12) is a distinct and removable component with respect to the pin means (18) and the pin means (18) are provided with, or are associated with, coupling means (15, 115) which are inserted into a mating seating (14) of the femoral head (12) in order to obtain a removable constraint between the latter and the pin means (18). The coupling means comprises a flange-type insert coupled eccentrically with the femoral head (12).
Patent DE-60332812-D1 (DE)
Inventor: BICEK ANDREW D
IPC: A61F2/06
Filed: 2003-01-08
Granted: 2010-07-15
Abstract: A stent comprises a plurality of axially spaced serpentine bands. Each serpentine band has a proximal and distal end and consists of a plurality of interconnected struts. The struts are of substantially the same length. Serpentine bands which are adjacent one another are connected one to the other. The stent further comprises a plurality of wishbone connectors. Each wishbone connector connects two serpentine bands which are adjacent one another. The wishbone connectors have an elongate portion which is disposed between the two serpentine bands and does not overlap longitudinally with either of the two serpentine bands. The elongate portion has a proximal end and a distal end. The proximal end has two legs extending therefrom to one of the two serpentine bands and the distal end has two legs extending therefrom to the other of the two serpentine bands. At least one wishbone connector connects serpentine bands which are adjacent one another.
Patent DE-60334802-D1 (DE)
Inventor: KATUSIC STIPAN
IPC: A61K8/27
Filed: 2003-07-07
Granted: 2010-12-16
Abstract: Doped zinc oxide powder comprises doping component (0.005-15 wt.%). The doping component comprises oxides of aluminum, gallium, indium, germanium, tin, and/or silicon. The zinc oxide powder is in the form of aggregates having a mean maximum diameter of 30-300 nm.  An Independent claim is also included for preparation of zinc oxide powder by treating zinc powder and doping agent(s) in vaporization, nucleation, oxidation, and quenching zones. In the vaporization zone, zinc powder is vaporized in a flame of air and/or oxygen and combustion gas under reaction conditions that oxidation of zinc does not occur. The hot reaction mixture from the vaporization zone containing zinc vapor, water vapor (reaction product of flame reaction), and optionally excess combustion gas passes through the nucleation zone and is cooled to 500-900degreesC or is cooled using inert gas, and an aerosol containing doping agent(s) is fed in an amount that corresponds to the desired amount of doping agent in the zinc oxide powder. In the oxidation zone, the mixture from the nucleation zone is oxidized with air and/or oxygen. In the quenching zone, the oxidation mixture is cooled to less than 400degreesC by addition of cooling gas.
Patent DE-68912235-D1 (DE)
Inventor: BLOOMSTER TIMOTHY G
IPC: G01N33/52
Filed: 1989-08-12
Granted: 1994-02-24
Abstract: A system having a coating station comprised of a dispensing assembly and a fluid collection head is useful to precisely coat reagents on porous supports for use in diagnostic devices. A cover having an aperture therethrough and the porous support secured to its underside covering the aperture is positioned in the coating station between the dispensing assembly and the fluid collection head. The reagent is dispensed from a cannula in the dispensing assembly onto the portion of the porous support exposed through the aperture of the cover. A reduced pressure in the fluid collection head pulls fluid through the porous support. The system is automated by providing a guide channel for holding a plurality of covers in correct orientation and a magazine for holding a stack of covers. An indexing arm delivers the bottom-most cover in the stack to the guide channel and urges covers in the channel along its length. The system includes reciprocating means to bring the dispensing assembly and fluid collection head to the cover for coating and away from the cover after coating. The dispensing assembly may include a template for coating the reagent in a distinct pattern. The system can include a plurality of coating stations to permit coating with a plurality of reagents.
Patent DE-68919660-D1 (DE)
Inventor: HOLT DENNIS ALAN
IPC: A61P35/00
Filed: 1989-12-19
Granted: 1995-01-12
Abstract: Compounds of structure (I) <CHEM> in which the dotted lines indicate the optional presence of a double bond, X<1>, X<2> and X<3> are H, halogen, CF3, C1-6alkyl, C1-6alkoxy, CN, NO2, N(R<1>)2, CHO or CO2R<1>; R<1> is H or C1-8alkyl and R is hydrogen, hydroxy or acetoxy; processes for their preparation, compositions containing them and their use in medicine as inhibitors of 5- alpha -reductase.
Patent DE-68920483-D1 (DE)
Inventor: GRAMMONT PAUL
IPC: A61B17/72
Filed: 1989-05-22
Granted: 1995-02-23
Abstract: The nail is characterised in that it comprises a system (1,2,3,4,5) capable of conferring upon it, and on the bone in which it is fixed, a progressive lengthening achieved automatically or by external action, the said system, with the exception of the fixation means, being entirely contained in the body and the bone in question without any element showing to the outside of the said body. 
<IMAGE>